Drug-induced psychosis in Parkinson disease: Phenomenology and correlations among psychosis rating instruments

Clinical Neuropharmacology

Volumn 28, Issue 5, 2005, Pages 215-219

  Chou, Kelvin L ^a,d   Messing, Susan ^b   Oakes, David ^b   Feldman, Peter D ^c   Breier, Alan ^c   Friedman, Joseph H ^c  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d NeuroHealth Parkinson's Disease and Movement Disorders Center   (United States)

Author keywords

Delusions; Hallucinations; Parkinson disease; Psychosis; Rating scales

Indexed keywords

OLANZAPINE;

AGED; AGITATION; ARTICLE; AUDITORY STIMULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; DOUBLE BLIND PROCEDURE; FEMALE; HALLUCINATION; HOSTILITY; HUMAN; LOCOMOTION; MAJOR CLINICAL STUDY; MALE; OLFACTORY SYSTEM; PARKINSON DISEASE; PHENOMENOLOGY; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK ASSESSMENT; SCHOOL CHILD; SLEEP; SYMPTOMATOLOGY; TACTILE STIMULATION; THOUGHT DISORDER; VISUAL HALLUCINATION;

AGED; DELUSIONS; DOUBLE-BLIND METHOD; FEMALE; HALLUCINATIONS; HUMANS; MALE; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 27644532055     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnf.0000180228.77802.32     Document Type: Article

References (19)

1. Factor SA, Molho ES, Podskalny GD, et al. Parkinson's disease: drug-induced psychiatric states. Adv Neurol. 1995;65:115-138.
2. Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain. 2000;123: 733-745.
3. Holroyd S, Currie L, Woolen GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001;70: 734-738.
4. Graham JM, Grunewald RA, Sagar HJ. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;63:434-440.
5. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol. 1996;53:1265-1268.
6. Celesia GG, Barr AN. Psychosis and other psychiatric manifestations of levodopa therapy. Arch Neurol. 1970;23:193-200.
7. Godwin-Austen RB. Psychosis and hallucinations in Parkinson's disease. Adv Neurol. 1999;80:401-402.
8. Goetz CG, Wuu J, Curgian LM, et al. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology. 2005;64:81-86.
9. Marsh L, Williams JR, Rocco M, et al. Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology. 2004;63:293-300.
10. Chacko RC, Hurley RA, Harper RG, et al. Clozapine for acute and maintenance treatment of psychosis in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1995;7:471-475.
11. Friedberg G, Zoldan J, Weizman A, et al. Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol. 1998;21:280-284.
12. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812.
13. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
14. Guy W. ECDEU assessment manual for psychopharmacology. Rev. Rockville, MD: Alcohol, Drug Abuse and Mental Health Administration; 1976.
15. Breier A, Sutton VK, Feldman PD, et al. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease. Biol Psychiatry. 2002;52:438-445.
16. Aarsland D, Larsen JP, Cummins JL, et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol. 1999;56:595-601.
17. Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry. 2001;70: 727-733.
18. Inzelberg R, Kipervasser S, Korczyn AD. Auditory hallucinations in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1998;64:533-535.
19. Friedman JH, Chou KL. Sleep and fatigue in Parkinson's disease. Parkinsonism Relat Disord. 2004;10(suppl 1):S27-S35.